Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Antibiotics biotech Nabriva shoots for a $92M IPO
Antibiotics biotech Nabriva shoots for a $92M IPO
Antibiotics biotech Nabriva shoots for a $92M IPO
Submitted by
admin
on June 19, 2015 - 10:07am
Source:
Fierce Biotech
News Tags:
Nabriva Therapeutics
IPOs
antibiotics
lefamulin
Headline:
Antibiotics biotech Nabriva shoots for a $92M IPO
Do Not Allow Advertisers to Use My Personal information